Free Trial

Abeona Therapeutics (ABEO) Competitors

Abeona Therapeutics logo
$5.90 +0.03 (+0.58%)
Closing price 07/3/2025 03:18 PM Eastern
Extended Trading
$5.90 -0.01 (-0.15%)
As of 07/3/2025 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ABEO vs. VRDN, BGM, MNKD, NAGE, LQDA, PCRX, ABCL, WVE, NVAX, and NTLA

Should you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Viridian Therapeutics (VRDN), BGM Group (BGM), MannKind (MNKD), Niagen Bioscience (NAGE), Liquidia Technologies (LQDA), Pacira BioSciences (PCRX), AbCellera Biologics (ABCL), WAVE Life Sciences (WVE), Novavax (NVAX), and Intellia Therapeutics (NTLA). These companies are all part of the "med - biomed/gene" industry.

Abeona Therapeutics vs. Its Competitors

Viridian Therapeutics (NASDAQ:VRDN) and Abeona Therapeutics (NASDAQ:ABEO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Viridian Therapeutics presently has a consensus price target of $37.56, indicating a potential upside of 140.97%. Abeona Therapeutics has a consensus price target of $19.25, indicating a potential upside of 226.05%. Given Abeona Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Abeona Therapeutics is more favorable than Viridian Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viridian Therapeutics
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90
Abeona Therapeutics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Abeona Therapeutics has higher revenue and earnings than Viridian Therapeutics. Abeona Therapeutics is trading at a lower price-to-earnings ratio than Viridian Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viridian Therapeutics$300K4,238.60-$269.95M-$3.85-4.05
Abeona Therapeutics$3.50M86.30-$63.73M-$1.27-4.65

Abeona Therapeutics has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -102,092.39%. Viridian Therapeutics' return on equity of -70.61% beat Abeona Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Viridian Therapeutics-102,092.39% -70.61% -44.67%
Abeona Therapeutics N/A -118.82%-52.48%

80.6% of Abeona Therapeutics shares are owned by institutional investors. 0.7% of Viridian Therapeutics shares are owned by company insiders. Comparatively, 5.4% of Abeona Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Abeona Therapeutics had 10 more articles in the media than Viridian Therapeutics. MarketBeat recorded 11 mentions for Abeona Therapeutics and 1 mentions for Viridian Therapeutics. Viridian Therapeutics' average media sentiment score of 0.72 beat Abeona Therapeutics' score of 0.26 indicating that Viridian Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Viridian Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Abeona Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Viridian Therapeutics has a beta of 0.39, suggesting that its stock price is 61% less volatile than the S&P 500. Comparatively, Abeona Therapeutics has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500.

Summary

Abeona Therapeutics beats Viridian Therapeutics on 10 of the 16 factors compared between the two stocks.

Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABEO vs. The Competition

MetricAbeona TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$301.31M$2.92B$5.56B$9.05B
Dividend YieldN/A2.44%5.24%3.99%
P/E Ratio-4.658.2819.9620.26
Price / Sales86.30283.26419.56119.26
Price / CashN/A41.7026.2128.59
Price / Book5.857.538.035.65
Net Income-$63.73M-$55.14M$3.18B$249.15M
7 Day Performance2.68%4.61%2.93%3.28%
1 Month Performance-12.40%0.90%1.72%3.95%
1 Year Performance30.04%5.40%34.39%20.98%

Abeona Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABEO
Abeona Therapeutics
4.0124 of 5 stars
$5.90
+0.6%
$19.25
+226.1%
+30.0%$301.31M$3.50M-4.6590News Coverage
VRDN
Viridian Therapeutics
1.777 of 5 stars
$13.98
-2.4%
$37.56
+168.6%
+26.5%$1.17B$300K0.0050News Coverage
BGM
BGM Group
N/A$10.59
-11.5%
N/AN/A$1.16B$25.10M0.00298News Coverage
Analyst Downgrade
MNKD
MannKind
2.5262 of 5 stars
$3.74
-0.5%
$10.33
+176.3%
-29.7%$1.14B$285.50M37.40400
NAGE
Niagen Bioscience
1.3093 of 5 stars
$14.41
+1.3%
$19.50
+35.3%
+406.4%$1.12B$99.60M158.00120
LQDA
Liquidia Technologies
3.2317 of 5 stars
$12.46
-4.9%
$26.89
+115.8%
+0.1%$1.12B$14M0.0050
PCRX
Pacira BioSciences
3.4447 of 5 stars
$23.90
+1.8%
$26.44
+10.6%
+10.2%$1.09B$700.97M10.34720
ABCL
AbCellera Biologics
2.4588 of 5 stars
$3.43
-5.0%
$8.33
+143.0%
+41.4%$1.08B$28.83M0.00500High Trading Volume
WVE
WAVE Life Sciences
4.4456 of 5 stars
$6.50
-2.5%
$20.50
+215.4%
+27.4%$1.04B$108.30M-7.74240News Coverage
NVAX
Novavax
4.4886 of 5 stars
$6.30
-1.1%
$17.00
+169.8%
-42.9%$1.03B$682.16M2.381,990
NTLA
Intellia Therapeutics
4.7197 of 5 stars
$9.38
-1.9%
$33.37
+255.7%
-52.9%$990.25M$57.88M0.00600News Coverage

Related Companies and Tools


This page (NASDAQ:ABEO) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners